Pioglitazone Induced Reversible Pancytopenia

被引：4

作者：

Karakurt, F. ^{[2
]}

Kargili, A. ^{[2
]}

Kasapoglu, B. ^{[1
]}

机构：

[1] Fatih Univ Hosp, Dept Internal Med, TR-06510 Ankara, Turkey

[2] Fatih Univ Hosp, Dept Endocrinol, TR-06510 Ankara, Turkey

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2010年 / 118卷 / 02期

关键词：

pioglitazone; diabetes mellitus type 2; pancytopenia; THIAZOLIDINEDIONES;

D O I：

10.1055/s-0029-1234065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pioglitazone is used to improve insulin sensitivity in type 2 diabetes. This group of drugs is usually well tolerated; however, their use may be associated with several adverse effects including edema, weight gain, macular edema and heart failure. Herein we report a patient who developed pancytopenia on the 7th day of oral pioglitazone treatment for the control of diabetes mellitus and fully recovered 6 days after the cessation of this drug. To the best of our knowledge this is the first reported case of pancytopenia induced by pioglitazone therapy.

引用

页码：96 / 97

页数：2

共 6 条

[1] Human bone marrow megakaryocytes and platelets express PPARγ, and PPARγ agonists blunt platelet release of CD40 ligand and thromboxanes
Akbiyik, F
Ray, DM
Gettings, KF
Blumberg, N
Francis, CW
Phipps, RP
[J]. BLOOD, 2004, 104 (05) : 1361 - 1368
[2] Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in type II diabetes mellitus
Berria, R.
Glass, L.
Mahankali, A.
Miyazaki, Y.
Monroy, A.
De Filippis, E.
Cusi, K.
Cersosimo, E.
DeFronzo, R. A.
Gastaldelli, A.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (03) : 275 - 281
[3] Leukopenia and thrombocytopenia caused by thiazolidinediones
Digman, C
Klein, AK
Pittas, AG
[J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (06) : 465 - 466
[4] Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
Lago, Rodrigo M.
Singh, Premranjan P.
Nesto, Richard W.
[J]. LANCET, 2007, 370 (9593) : 1129 - 1136
[5] Mild, reversible pancytopenia induced by rosiglitazone
Maaravi, Y
Stessman, J
[J]. DIABETES CARE, 2005, 28 (06) : 1536 - 1536
[6] Rizos CV, 2009, EXPERT OPIN DRUG SAF, V8, P15, DOI [10.1517/14740330802597821 , 10.1517/14740330802597821]

← 1 →